Journal of Medical Signals & Sensors, published by Wolters Kluwer Medknow Publications, is a pioneering platform in the fields of Biomedical Engineering, Computer Science, and Health Informatics, focusing on innovative research and advancements in medical technology. With an Open Access policy since 2012, the journal promotes widespread dissemination of knowledge, aiming to facilitate the sharing of vital insights and developments among researchers, healthcare professionals, and students globally. The journal has achieved commendable rankings in its various categories, including Q3 in Biomedical Engineering and Radiology, underscoring its importance in advancing health technology and informatics. Its commitment to rigorous peer review ensures that published works are of the highest quality, making it a valuable resource for those engaged in cutting-edge medical research. With annual publications planned through 2024, the Journal of Medical Signals & Sensors continues to expand its influence and relevance in a rapidly evolving scientific landscape.

BME Frontiers, published by the American Association for the Advancement of Science, is an innovative open-access journal dedicated to the burgeoning field of Biomedical Engineering. Since its establishment in 2020, this journal has aimed to bridge the gap between cutting-edge research and practical application, promoting advancements in biomedical technologies, medical devices, and healthcare solutions. Boasting impressive rankings within Scopus—64th among 398 in Medicine (miscellaneous) and 81st among 303 in Biomedical Engineering—BME Frontiers stands out as a significant contributor to scholarly communication, offering rich insights for researchers, professionals, and students alike. With consistent publication projected through 2024, the journal serves as an essential platform for disseminating high-quality research that can drive innovation and inspire new approaches in the healthcare sector.

Biomedical Physics & Engineering Express, published by IOP Publishing Ltd, serves as a dynamic platform for the dissemination of groundbreaking research in the interdisciplinary domains of biomedical physics, engineering, and related fields. With a focus on innovative solutions for healthcare challenges, the journal extends its reach to a global audience, providing valuable insights that influence both academic research and practical applications. Operating under an open-access format, this journal ensures that vital scientific discoveries are readily available to researchers, professionals, and students alike. Ranking within the Q3 and Q4 quartiles across various categories—including Bioengineering and Biomedical Engineering—indicates its emerging influence in the scientific community since its inception in 2015. With an increasing footprint in Scopus rankings and a commitment to advancing knowledge in subfields such as biophysics and health informatics, Biomedical Physics & Engineering Express plays a crucial role in shaping future innovations in healthcare technology and patient care.

Biocybernetics and Biomedical Engineering, published by ELSEVIER in the Netherlands, is a prestigious journal that stands at the forefront of the intersecting fields of biomedical engineering and artificial intelligence. With an impressive Impact Factor that places it in the Q1 category for Biomedical Engineering, this journal not only ranks 17th out of 303 in Scopus but also boasts a remarkable percentile ranking of 94th, highlighting its influence and relevance within the scientific community. Since its inception in 2008, Biocybernetics and Biomedical Engineering has aimed to publish cutting-edge research that integrates principles of cybernetics with technological advancements in health care, thereby fostering innovations that improve patient outcomes. Dedicated to advancing knowledge in biomedical technology, the journal serves as a vital resource for researchers, professionals, and students seeking to explore the latest developments and methodologies in the field.

Bioengineering & Translational Medicine, published by WILEY, positions itself at the forefront of innovation in the fields of biomedical engineering, biotechnology, and pharmaceutical science. With an impressive impact factor reflected through its top-tier Q1 rankings in multiple categories, the journal serves as a critical platform for disseminating cutting-edge research and stimulating discourse among professionals and scholars since its establishment as an open-access journal in 2016. Key to its mission is facilitating the translation of bioengineering research into tangible medical applications, thereby enhancing healthcare outcomes. With its comprehensive scope, it attracts a diverse readership, including researchers, industry leaders, and students eager to engage with the latest developments in translational medicine. The journal operates under robust access options, ensuring that research is freely available for maximum reach and impact, fostering collaboration and innovation across disciplines worldwide.

BIO-MEDICAL MATERIALS AND ENGINEERING, published by IOS PRESS, serves as a vital platform for advancing the fields of biomaterials and biomedical engineering. With its ISSN 0959-2989 and E-ISSN 1878-3619, the journal has been consistently disseminating high-quality research since its inception in 1991, covering a diverse range of studies on the development and application of biomedical materials. Although currently classified in the Q4 quartile in several categories including biomaterials and biomedical engineering, the journal aims to appeal to a broad audience of researchers and professionals, fostering collaboration and innovation in translating new materials into clinical practice. Located in the Netherlands, it emphasizes the importance of interdisciplinary approaches and provides a forum for new ideas and findings that could significantly impact healthcare solutions. While not an open-access journal, it provides various access options to maximize the reach and engagement of its research. Researchers, practitioners, and students alike will find valuable insights and comprehensive studies within its pages, contributing to the continued evolution of biomedical sciences.

The International Journal of Biomedical Engineering and Technology, published by INDERSCIENCE ENTERPRISES LTD, serves as a pivotal platform for the dissemination of innovative research in the field of biomedical engineering. This journal, with ISSN 1752-6418 and E-ISSN 1752-6426, has been a valuable resource since its inception in 2007, boasting a converged publication timeline extending to 2024. Based in the United Kingdom, the journal aims to bridge the gap between engineering and biomedical sciences, facilitating interdisciplinary collaboration. As reflected in its 2023 Scopus ranking in the Q4 quartile of Biomedical Engineering, the journal remains accessible for researchers at various stages of their careers, contributing to its significance in promoting advancements in healthcare technologies. While currently not an open-access publication, the journal remains dedicated to enriching the biomedical engineering community by presenting novel research that addresses critical challenges, ultimately aiming to improve patient outcomes and drive innovation in medical devices and therapies.

IRBM, published by Elsevier Science Inc, stands at the forefront of research in the domains of Biomedical Engineering and Biophysics, boasting impressively high rankings with a Q1 category in both fields according to the 2023 evaluations. With an effective focus on cutting-edge innovations and methodologies, IRBM provides a vital platform for researchers, professionals, and students alike seeking to disseminate and access groundbreaking findings and developments. Its strong presence in the Scopus database, with ranks of #12 in Biochemistry, Genetics and Molecular Biology and #42 in Biomedical Engineering, places it in the top percentile of impactful journals in the field, making it a crucial resource for advancing knowledge and fostering collaboration. While the journal maintains a traditional subscription model, it continues to attract a diverse readership eager for insightful studies and reviews that push the boundaries of science and engineering. With a projected convergence of years extending to 2024, IRBM promises to remain a significant contributor to the ongoing dialogue in the life sciences.

IET Nanobiotechnology, published by WILEY-HINDAWI in the United Kingdom, is a leading journal dedicated to advancing the field of nanobiotechnology by exploring the interplay between nanotechnology and biological systems. With an impressive impact factor and a significant coverage in Scopus rankings, this journal occupies a pivotal position within the Q2 and Q3 quartiles across various relevant disciplines, including Biotechnology, Electrical and Electronic Engineering, and Nanoscience. Since its inception in 2007, the journal has showcased a diverse range of high-quality research that facilitates the development of innovative nanomaterials and their applications in medicine, biosensing, and bioengineering. Open access to its articles ensures that cutting-edge advancements are readily accessible to the global research community, fostering collaboration and knowledge sharing. As the field of nanobiotechnology continues to evolve, IET Nanobiotechnology remains a crucial resource for researchers, professionals, and students striving to shape the future of this interdisciplinary domain.

Biomedical Engineering-Biomedizinische Technik, published by WALTER DE GRUYTER GMBH, serves as a pivotal platform for advancing knowledge in the field of biomedical engineering and medicine since its inception in 1956. With an ISSN of 0013-5585 and an E-ISSN of 1862-278X, this peer-reviewed journal offers accessible insights into innovative research and technological advancements that are reshaping healthcare practices and biomedical applications. Although rated in the Q3 category for both Biomedical Engineering and Miscellaneous Medicine in 2023, the journal's impact factor and growing reputation demonstrate its vital role in fostering academic dialogue and collaboration. The journal is based in Germany, while its scope encompasses a diverse range of topics, thus bridging the gap between engineering and medical disciplines. Researchers, professionals, and students alike are encouraged to engage with the content that not only highlights contemporary challenges but also presents groundbreaking solutions in biomedical technology.